Additionally, GDF-15 is a novel regulator of PD-L1 expression in glioblastoma multiforme (GBM); thus, targeting the GDF15/PD-L1 pathway might be a promising treatment for GBM patients [26]. The gene discussed is GDF15; the disease is glioblastoma.